期刊文献+

Mitochondrial Dysfunction and Alzheimer’s Disease

Mitochondrial Dysfunction and Alzheimer’s Disease
下载PDF
导出
摘要 Alzheimer’s disease (AD) is a neurodegenerative disorder that is characterized by progressive loss of basal forebrain cholinergic neurons, leading to reduction in transmission through cholinergic fibers involved in processes of attention, learning, and memory. Mitochondria provide and regulate cellular energy and are crucial for proper neuronal activity and survival. Mitochondrial dysfunction is evident in early stages of AD and is involved in AD pathogenesis. This review focuses on the evidence supporting a clear association between amyloid-β toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage/death in Alzheimer’s disease. To date, the beta amyloid (Aβ) cascade hypothesis still remains the main pathogenetic model of Alzheimer’s disease (AD), but its role in the majority of sporadic AD cases is uncertain. Furthermore, the “mitochondrial cascade hypothesis” could explain many of the biochemical, genetic, and pathological features of sporadic AD. This hypothesis promotes mutations in mitochondrial DNA (mtDNA) as the basis for Alzheimer’s disease. The mutations could lead to energy failure, increased oxidative stress, and accumulation of Aβ, which in a vicious cycle reinforces the mtDNA damage and oxidative stress. Alzheimer’s disease (AD) is a neurodegenerative disorder that is characterized by progressive loss of basal forebrain cholinergic neurons, leading to reduction in transmission through cholinergic fibers involved in processes of attention, learning, and memory. Mitochondria provide and regulate cellular energy and are crucial for proper neuronal activity and survival. Mitochondrial dysfunction is evident in early stages of AD and is involved in AD pathogenesis. This review focuses on the evidence supporting a clear association between amyloid-β toxicity, mitochondrial dysfunction, oxidative stress and neuronal damage/death in Alzheimer’s disease. To date, the beta amyloid (Aβ) cascade hypothesis still remains the main pathogenetic model of Alzheimer’s disease (AD), but its role in the majority of sporadic AD cases is uncertain. Furthermore, the “mitochondrial cascade hypothesis” could explain many of the biochemical, genetic, and pathological features of sporadic AD. This hypothesis promotes mutations in mitochondrial DNA (mtDNA) as the basis for Alzheimer’s disease. The mutations could lead to energy failure, increased oxidative stress, and accumulation of Aβ, which in a vicious cycle reinforces the mtDNA damage and oxidative stress.
机构地区 Ball State University
出处 《Open Journal of Endocrine and Metabolic Diseases》 2013年第2期14-19,共6页 内分泌与新陈代谢疾病期刊(英文)
关键词 Alzheimer’s MITOCHONDRIA CYBRID OXIDATIVE STRESS Alzheimer’s Mitochondria Cybrid Oxidative Stress
  • 相关文献

参考文献1

二级参考文献91

  • 1Claire Shepherd,Heather McCann,Glenda Margaret Halliday.Variations in the neuropathology of familial Alzheimer’s disease[J]. Acta Neuropathologica . 2009 (1)
  • 2A. J. Larner,M. Doran.Clinical phenotypic heterogeneity of Alzheimer’s disease associated with mutations of the presenilin–1 gene[J]. Journal of Neurology . 2006 (2)
  • 3Masaki Takao,Bernardino Ghetti,Isao Hayakawa,Eiji Ikeda,Yasuo Fukuuchi,Leticia Miravalle,Pedro Piccardo,Jill R. Murrell,Bradley S. Glazier,Atsuo Koto.A novel mutation (G217D) in the Presenilin 1 gene (PSEN1) in a Japanese family: presenile dementia and parkinsonism are associated with cotton wool plaques in the cortex and striatum[J]. Acta Neuropathologica . 2002 (2)
  • 4Giacomello M,Barbiero L,Zatti G,et al.Reduction of Ca2+stores and capacitative Ca2+entry is associated with the familial Alzheimer’’s disease presenilin-2 T122R mutation and anticipates the onset of dementia. Neurobiology of Disease . 2005
  • 5Zhang H,Sun S,Herreman A,et al.Role of presenilins in neuronal calcium homeostasis. The Journal of Neuroscience . 2010
  • 6Nelson O,Supnet C,Liu H,et al.Familial Alzheimer’’s diseasemutations in presenilins:effects on endoplasmic reticulum calcium homeostasis and correlation with clinical phenotypes. Journal of Alzheimer s Disease . 2010
  • 7Tolia A,Horre K,De Strooper B.Transmembrane domain 9 of presenilin determines the dynamic conformation of the catalytic site of gamma-secretase. Journal of Biological Chemistry . 2008
  • 8Sobhanifar S,,Schneider B,Lohr F,et al.Structural investigation of the C-terminal catalytic fragment of presenilin 1. Proceedings of the National Academy of Sciences of the United States of America . 2010
  • 9Nelson O,Supnet C,Tolia A,et al.Mutagenesis mapping of the pre- senilin 1 calcium leak conductance pore. Journal of Biological Chemistry . 2011
  • 10Cervantes S,Saura C A,Pomares E,et al.Functional implications of the presenilin dimerization:reconstitution of gamma-secretase activity by assembly of a catalytic site at the dimer interface of two catalytically inactive presenilins. Journal of Biological Chemistry . 2004

共引文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部